NO20003057L - Indolderivater som inhibitorer av faktor Xa - Google Patents

Indolderivater som inhibitorer av faktor Xa

Info

Publication number
NO20003057L
NO20003057L NO20003057A NO20003057A NO20003057L NO 20003057 L NO20003057 L NO 20003057L NO 20003057 A NO20003057 A NO 20003057A NO 20003057 A NO20003057 A NO 20003057A NO 20003057 L NO20003057 L NO 20003057L
Authority
NO
Norway
Prior art keywords
inhibitors
factor
indole derivatives
indole
derivatives
Prior art date
Application number
NO20003057A
Other languages
English (en)
Other versions
NO316912B1 (no
NO20003057D0 (no
Inventor
Elisabeth Defossa
Uwe Heinelt
Otmar Klingler
Gerhard Zoller
Fahad Al-Obeidi
Armin Walser
Peter Wildgoose
Hans Matter
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20003057D0 publication Critical patent/NO20003057D0/no
Publication of NO20003057L publication Critical patent/NO20003057L/no
Publication of NO316912B1 publication Critical patent/NO316912B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003057A 1997-12-24 2000-06-14 Indolderivater som inhibitorer av faktor Xa NO316912B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97122901 1997-12-24
PCT/EP1998/008030 WO1999033800A1 (en) 1997-12-24 1998-12-10 Indole derivatives as inhibitors or factor xa

Publications (3)

Publication Number Publication Date
NO20003057D0 NO20003057D0 (no) 2000-06-14
NO20003057L true NO20003057L (no) 2000-08-18
NO316912B1 NO316912B1 (no) 2004-06-21

Family

ID=8227884

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003057A NO316912B1 (no) 1997-12-24 2000-06-14 Indolderivater som inhibitorer av faktor Xa

Country Status (29)

Country Link
US (1) US6337344B1 (no)
EP (1) EP1042287B1 (no)
JP (1) JP4589529B2 (no)
KR (1) KR100608472B1 (no)
CN (1) CN1220681C (no)
AR (1) AR018031A1 (no)
AT (1) ATE293599T1 (no)
AU (1) AU743881B2 (no)
BR (1) BR9814340B1 (no)
CA (1) CA2316172C (no)
CZ (1) CZ298827B6 (no)
DE (1) DE69829879T2 (no)
DK (1) DK1042287T3 (no)
ES (1) ES2241194T3 (no)
HK (1) HK1033795A1 (no)
HU (1) HU227568B1 (no)
ID (1) ID27044A (no)
IL (1) IL136954A0 (no)
MY (1) MY120064A (no)
NO (1) NO316912B1 (no)
NZ (1) NZ505370A (no)
PL (1) PL195682B1 (no)
PT (1) PT1042287E (no)
RU (1) RU2225397C2 (no)
SI (1) SI1042287T1 (no)
TR (1) TR200001954T2 (no)
TW (1) TWI241294B (no)
WO (1) WO1999033800A1 (no)
ZA (1) ZA9811759B (no)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
EP1042287B1 (en) * 1997-12-24 2005-04-20 Aventis Pharma Deutschland GmbH Indole derivatives as inhibitors of factor xa
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
DE19917504A1 (de) * 1999-04-17 2000-10-19 Dresden Arzneimittel Verwendung von Hydroxyindolen, die Inhibitoren der Phosphodiesterase 4 sind, zur Therapie chronisch obstruktiver Lungenerkrankungen
IL144096A0 (en) 1999-01-02 2002-05-23 Aventis Pharma Gmbh Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity)
IL144095A0 (en) 1999-01-02 2002-05-23 Aventis Pharma Gmbh Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
GB9902459D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
AR024158A1 (es) * 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
EP1095933A1 (en) 1999-10-30 2001-05-02 Aventis Pharma Deutschland GmbH Novel N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
EP1127884A1 (en) 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
GB0005366D0 (en) * 2000-03-06 2000-04-26 Xenova Ltd Pharmaceutical compounds
WO2001072708A2 (en) * 2000-03-24 2001-10-04 Cor Therapeutics, Inc. OXINDOLE INHIBITORS OF FACTOR Xa
US6670388B1 (en) 2000-06-27 2003-12-30 Smithkline Beecham Corporation Fatty acid synthase inhibitors
US20040067938A1 (en) * 2000-09-29 2004-04-08 Penglie Zhang Quaternary amines and related inhibitors of factor xa
PT1404653E (pt) 2001-06-28 2008-09-23 Pfizer Prod Inc Compostos heterobicíclicos triamida-substituídos
DE10147672A1 (de) 2001-09-27 2003-04-10 Bayer Ag Substituierte 2,5-Diamidoindole und ihre Verwendung
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
WO2003078448A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
US7317027B2 (en) * 2003-05-19 2008-01-08 Sanofi-Aventis Deutschland Gmbh Azaindole-derivatives as factor Xa inhibitors
EP1479680A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Azaindole derivatives as Factor Xa inhibitors
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
SE0302035D0 (sv) * 2003-07-09 2003-07-09 Biolipox Ab New compound
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
KR101415503B1 (ko) * 2003-07-17 2014-07-04 플렉시콘, 인코퍼레이티드 Ｐｐａｒ 활성 화합물
US7186084B2 (en) * 2003-11-19 2007-03-06 General Electric Company Hot gas path component with mesh and dimpled cooling
EP1568698A1 (en) * 2004-02-27 2005-08-31 Aventis Pharma Deutschland GmbH Pyrrole-derivatives as factor Xa inhibitors
EP1765775B1 (en) * 2004-06-18 2009-04-29 Biolipox AB Indoles useful in the treatment of inflammation
AU2005254782A1 (en) * 2004-06-18 2005-12-29 Biolipox Ab Indoles useful in the treatment of inflammation
CA2570531A1 (en) * 2004-06-18 2005-12-29 Kristofer Olofsson Indoles useful in the treatment of inflammation
EP1791810A1 (en) * 2004-09-06 2007-06-06 F. Hoffmann-Roche AG 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors
EP1807082A4 (en) 2004-10-26 2010-12-01 Janssen Pharmaceutica Nv INHIBITOR COMPOUNDS OF XA FACTORS
GB0428173D0 (en) * 2004-12-23 2005-01-26 Astrazeneca Ab Compounds
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
JP2008527028A (ja) * 2005-01-19 2008-07-24 バイオリポックス エービー 炎症の治療に有用なインドール類
BRPI0519774A2 (pt) * 2005-01-19 2009-02-10 Biolipox Ab composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
EP1841766A1 (en) * 2005-01-19 2007-10-10 Biolipox AB Pyrrolopyridines useful in the treatment of inflammation
US20090069384A1 (en) * 2005-01-19 2009-03-12 Biolipox Ab Thienopyrroles useful in the treatment of inflammation
JP2008527030A (ja) * 2005-01-19 2008-07-24 バイオリポックス エービー 炎症の治療に有用なインドール類
CA2594878A1 (en) * 2005-01-19 2006-07-27 Biolipox Ab Indoles useful in the treatment of inflammation
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US8221804B2 (en) * 2005-02-03 2012-07-17 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1747779A1 (en) 2005-07-28 2007-01-31 Laboratorios Del Dr. Esteve, S.A. Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
CN101304992A (zh) * 2005-09-07 2008-11-12 普莱希科公司 用作ppar调节剂的1,3-二取代吲哚衍生物
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
AU2007281220B2 (en) 2006-07-31 2013-08-15 Activesite Pharmaceuticals, Inc. Inhibitors of plasma kallikrein
JP5249226B2 (ja) * 2006-09-13 2013-07-31 サノフイ 凝固第ＩＸａ因子インヒビターとしての使用のためのイソセリン誘導体
WO2008042571A2 (en) * 2006-09-29 2008-04-10 Smithkline Beecham Corporation Substituted indole compounds
KR20090076962A (ko) 2006-11-09 2009-07-13 에프. 호프만-라 로슈 아게 인돌 및 벤조퓨란 2-카복스아마이드 유도체
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
NZ582056A (en) * 2007-08-10 2012-08-31 Lundbeck & Co As H Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation
CN102014897B (zh) 2008-04-21 2015-08-05 西格纳姆生物科学公司 化合物、组合物和其制备方法
CN101654427B (zh) * 2008-08-19 2012-12-05 信谊药厂 抗凝化合物、组合物及其用途
US8575186B2 (en) 2009-10-05 2013-11-05 Albany Molecular Research, Inc. Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
JP2013515000A (ja) * 2009-12-18 2013-05-02 アクティベサイト ファーマシューティカルズ インコーポレイティッド 血漿カリクレインの阻害薬のプロドラッグ
US9206123B2 (en) 2009-12-18 2015-12-08 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
WO2012099952A2 (en) 2011-01-19 2012-07-26 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
TW201309698A (zh) 2011-03-18 2013-03-01 Ono Pharmaceutical Co 四氫咔啉衍生物
US8691861B2 (en) 2011-04-13 2014-04-08 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
CN108602775B (zh) 2016-01-14 2022-04-29 贝思以色列女会吏医学中心公司 肥大细胞调节剂及其用途
US11883381B2 (en) 2016-05-12 2024-01-30 The Regents Of The University Of Michigan ASH1L inhibitors and methods of treatment therewith
JP2021502388A (ja) 2017-11-10 2021-01-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Ａｓｈ１ｌ阻害剤及びそれを用いた治療方法
EP4149458A4 (en) * 2020-05-11 2024-06-05 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University COMPOSITIONS OF TRYPTOPHOL DERIVATIVES AND 4-ETHYL-PHENOL DERIVATIVES, AND METHODS OF USE THEREOF
WO2023068700A1 (ko) * 2021-10-20 2023-04-27 동국대학교 와이즈캠퍼스 산학협력단 두룸아마이드 a를 포함하는 혈소판 응집 예방, 개선 또는 치료용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529724A (en) * 1983-10-11 1985-07-16 Mcneilab, Inc. 6H-indolo[2,1-c][1,4]benzodiazepines and 12-oxo derivatives useful as antihypertensives
DD235866B1 (de) 1985-03-29 1988-12-28 Univ Leipzig Verfahren zur herstellung von n alpha (2-naphthyl)-sulfonylaminoacylierten amidinophenylalanisamiden
JP3655632B2 (ja) 1994-04-26 2005-06-02 アベンティス・ファーマスーティカルズ・インコーポレイテッド 第Ｘａ因子インヒビター
US5612363A (en) * 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants
DE19530996A1 (de) 1995-08-23 1997-02-27 Boehringer Mannheim Gmbh Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel
US5849759A (en) 1995-12-08 1998-12-15 Berlex Laboratories, Inc. Naphthyl-substituted benzimidazole derivatives as anti-coagulants
DE69717268T2 (de) * 1996-02-22 2003-09-04 Bristol-Myers Squibb Pharma Co., Wilmington M-amidinophenyl-analoga als faktor-xa-inhibitoren
US6200969B1 (en) * 1996-09-12 2001-03-13 Idun Pharmaceuticals, Inc. Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
US6184244B1 (en) * 1996-12-16 2001-02-06 Idun Pharmaceuticals, Inc. C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
US5886191A (en) * 1997-08-18 1999-03-23 Dupont Pharmaceuticals Company Amidinoindoles, amidinoazoles, and analogs thereof
EP1042287B1 (en) * 1997-12-24 2005-04-20 Aventis Pharma Deutschland GmbH Indole derivatives as inhibitors of factor xa

Also Published As

Publication number Publication date
NZ505370A (en) 2002-06-28
AR018031A1 (es) 2001-10-31
ES2241194T3 (es) 2005-10-16
CN1283186A (zh) 2001-02-07
CA2316172A1 (en) 1999-07-08
RU2225397C2 (ru) 2004-03-10
CZ20002310A3 (cs) 2000-10-11
JP4589529B2 (ja) 2010-12-01
BR9814340B1 (pt) 2010-07-13
AU2052899A (en) 1999-07-19
WO1999033800A1 (en) 1999-07-08
PL195682B1 (pl) 2007-10-31
EP1042287A1 (en) 2000-10-11
EP1042287B1 (en) 2005-04-20
BR9814340A (pt) 2000-10-03
HU227568B1 (en) 2011-08-29
ID27044A (id) 2001-02-22
HUP0100723A3 (en) 2002-12-28
KR100608472B1 (ko) 2006-08-09
MY120064A (en) 2005-08-30
ATE293599T1 (de) 2005-05-15
CZ298827B6 (cs) 2008-02-20
JP2001527066A (ja) 2001-12-25
SI1042287T1 (en) 2005-10-31
DK1042287T3 (da) 2005-08-15
NO316912B1 (no) 2004-06-21
NO20003057D0 (no) 2000-06-14
CN1220681C (zh) 2005-09-28
DE69829879T2 (de) 2006-03-02
HUP0100723A2 (hu) 2001-08-28
IL136954A0 (en) 2001-06-14
KR20010033573A (ko) 2001-04-25
PT1042287E (pt) 2005-08-31
TR200001954T2 (tr) 2000-12-21
HK1033795A1 (en) 2001-09-21
TWI241294B (en) 2005-10-11
AU743881B2 (en) 2002-02-07
US6337344B1 (en) 2002-01-08
PL341400A1 (en) 2001-04-09
DE69829879D1 (de) 2005-05-25
CA2316172C (en) 2010-02-02
ZA9811759B (en) 1999-07-28

Similar Documents

Publication Publication Date Title
NO20003057D0 (no) Indolderivater som inhibitorer av faktor Xa
NO20001687D0 (no) Benzamidinderivater som faktor Xa-inhibitorer
NO975740L (no) Arylsulfonylaminobenzenderivater og deres anvendelse som faktor Xa-inhibitorer
NO20002958D0 (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
NO992633D0 (no) Nitrogenholdige heteroaromatiske forbindelser som faktor Xa-inhibitorer
DK1140941T3 (da) Nitrogenholdige heterobicykliske forbindelser som faktor Xa-inhibitorer
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
NO20021230D0 (no) Inhibitorer for faktor Xa
AU6762400A (en) Inhibitors of factor xa
AU5283800A (en) Inhibitors of factor xa
AU5158100A (en) Inhibitors of factor xa
AU5283900A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
AU5284000A (en) Inhibitors of factor xa
NO974043L (no) Indolderivater som EAA-antagonister
AU2001249397A1 (en) Oxindole inhibitors of factor xa
NO20003315L (no) Indol-derivater anvendelige bl a for behandling av osteoporose
NO20001200D0 (no) Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase
NO20016403L (no) Substituerte purinderivater som inhibitorer av celleadhesjon
NO20015033L (no) Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner
AU6002700A (en) Heterocyclic derivatives as inhibitors of factor xa
NO20021249L (no) Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater anvendbare som D4antagonister
AU4900397A (en) Heterocyclic derivatives as factor xa inhibitors
NO20000860D0 (no) Syklopeptidderivater som adhesjonsinhibitorer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees